Menu
Home
Vision
Mission
About Us
ABOUT EVA GROUP
ABOUT EVA PHARMA
Quality
Meet Our Leaders
R&D
Products
Therapeutic Area
Products Portofolio
EU-CTD List OCT
Covid-19 Products
Partnerships
News and Media
Positive Impact
Careers
Find a Job
Find an Internship
Life at Eva pharma
Training and Development
Contact US
English
Arabic
Search
Latest News
EVA Group and Lilly enter into a partnership in Egypt
Read More
›
EVA Pharma Launches its Immunity Booster Limitless Zinc® Tablets
Read More
›
U.S. Food and Drug Administration (FDA) Approved Remdesivir as the only Treatment for COVID-19
Read More
›
EVA Pharma Launches the First Egyptian Generic for Type 2 Diabetes Treatment Diaflozimet® Tablets
Read More
›
EVA Pharma starts export of COVID-19 Antiviral Avipiravir® Worldwide
Read More
›
FDA Broadens Emergency Use Authorization for Remdesivir to Include All Hospitalized Patients for Treatment of COVID-19
Read More
›
Two Egyptian-Manufactured Medicines are Soon Entering Europe and Canada
Read More
›
EVA Pharma Talent Academy Equips 3 Thousands Pharmacy Students for the Job Market
Read More
›
EVA Pharma Releases 500 Thousand Packs of the Analgesic and Antipyretic Drug Paracetamol under the Trade Name Stopadol®
Read More
›
The Supreme Committee for Viruses Recognizes EVA Pharma as a Partner in the Eradication of Virus C in Egypt
Read More
›
EVA Pharma Explores the Manufacturing of COVID-19 Vaccines with European and American Companies
Read More
›
The Telegraph announced that “Sofosbuvir” and “Daclatasvir” Produced by EVA Pharma are reducing Coronavirus Death Rate
Read More
›
Name
Email*